ALEXANDRIA, Va., July 21 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'RYPLAZIM PLASMINOGEN' in its latest official gazette. The trademark application with the serial number 87247936 was filed on Nov. 25, 2016.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies
International/US Class(es): 5
Mark Drawing Code: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
Current Owner(s): KEDRION BIOPHARMA INC. 400 KELBY STREET, SUITE 1200 FORT LEE NJ NEW JERSEY 07024 3 CORPORATION
Disclaimer: Curated by HT Syndication....